Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
WuXi PharmaTech, one of China’s most visible...
Chongqing Zhifei Biological Products bid $93 million for...
It's earnings season, and almost every day for the past...
At the recent ChinaBio® Partnering Forum, three...
Bristol-Myers Squibb expects China to become its second...
WuXi PharmaTech, the NY-listed CRO, reported Q2 revenues...
ShangPharma, a CRO that listed on the NYSE in late 2010,...
The US plans to raise $299 million in fees to fund...
WuXi PharmaTech plans to begin offering clinical trial...
Shanghai Pharma is seeking to acquire a mid-sized US or...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
